Latest Sirolimus Stories
FT. LAUDERDALE, Fla., Jan. 4, 2011 /PRNewswire/ -- OrbusNeich today announced that the United States Patent and Trademark Office (USPTO) has granted an additional patent expanding protection of the company's Genous endothelial progenitor cell (EPC) capture technology. The patent (U.S. Pat. No.
Whitehead Institute researchers have linked hyperactivity in the mechanistic target of rapamycin complex 1 (mTORC1) cellular pathway, to reduced ketone production, which is a well-defined physiological trait of aging in mice.
Today Insightra Medical, one of the fastest growing medical device companies announced the expansion of cardiology products by the addition of a line of Coronary Dilatation Balloons (CDB). Irvine, CA (PRWEB) December 12, 2010 Insightra Medical, Irvine, CA, is aggressively targeting three major sectors of the medical device market: Cardiovascular, General Surgery and Urogynecology.
EAST HANOVER, N.J., Dec.
HONG KONG, Dec.
DURHAM, N.C., Nov. 29, 2010 /PRNewswire/ -- Micell Technologies,(TM) Inc.
HONG KONG, Nov.
NEW YORK, Nov. 19, 2010 /PRNewswire-FirstCall/ -- Pfizer Inc.
EAST HANOVER, N.J., Nov.
SILVER SPRING, Md., Oct. 30 /PRNewswire/ -- The Tuberous Sclerosis Alliance (TS Alliance) today announced the first drug approved for a tuberous sclerosis complex (TSC) indication by the Federal Drug Administration (FDA).
- A woman chauffeur.
- A woman who operates an automobile.